Richard E Champlin

Richard E Champlin

UNVERIFIED PROFILE

Are you Richard E Champlin?   Register this Author

Register author
Richard E Champlin

Richard E Champlin

Publications by authors named "Richard E Champlin"

Are you Richard E Champlin?   Register this Author

100Publications

3902Reads

34Profile Views

Curative potential of hematopoietic stem cell transplantation for advanced psoriasis.

Am J Hematol 2019 Jun 3;94(6):E176-E180. Epub 2019 Apr 3.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25470DOI Listing
June 2019

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.

Curr Res Transl Med 2019 May 23;67(2):51-55. Epub 2019 Jan 23.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.retram.2019.01.001DOI Listing
May 2019

Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma.

EBioMedicine 2019 Jan 10;39:612-620. Epub 2018 Dec 10.

Department of Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2018.12.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354702PMC
January 2019

Sensitive PCR-based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation.

Br J Haematol 2018 12 19;183(5):831-835. Epub 2017 Dec 19.

Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15059DOI Listing
December 2018

Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells.

Exp Hematol 2018 11 10;67:49-59.e1. Epub 2018 Aug 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2018.08.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262883PMC
November 2018

CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes.

Biol Blood Marrow Transplant 2018 10 20;24(10):2017-2024. Epub 2018 Jun 20.

Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.06.016DOI Listing
October 2018

Neurocognitive deficits in older patients with cancer.

J Geriatr Oncol 2018 09 9;9(5):482-487. Epub 2018 Mar 9.

Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2018.02.010DOI Listing
September 2018

Overall survival in older patients with cancer.

BMJ Support Palliat Care 2018 Sep 22. Epub 2018 Sep 22.

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjspcare-2018-001516DOI Listing
September 2018

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2018 07 12;24(7):1514-1520. Epub 2018 Feb 12.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.02.003DOI Listing
July 2018

Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study.

Transpl Int 2018 06 13;31(6):639-648. Epub 2018 Mar 13.

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/tri.13142
Publisher Site
http://dx.doi.org/10.1111/tri.13142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948153PMC
June 2018

Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience.

Support Care Cancer 2018 May 2;26(5):1561-1568. Epub 2017 Dec 2.

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3962-7DOI Listing
May 2018

Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma.

Qual Life Res 2018 Apr 19;27(4):979-985. Epub 2017 Dec 19.

Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-017-1759-2DOI Listing
April 2018

Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation.

Arch Osteoporos 2018 Apr 4;13(1):38. Epub 2018 Apr 4.

Department of General Internal Medicine, Section of Rheumatology and Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11657-018-0453-5DOI Listing
April 2018

Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation.

Biol Blood Marrow Transplant 2018 02 3;24(2):353-358. Epub 2017 Oct 3.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.09.018DOI Listing
February 2018

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.

Biol Blood Marrow Transplant 2017 Dec 24;23(12):2166-2171. Epub 2017 Aug 24.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889108PMC
December 2017

Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.

Eur J Haematol 2017 Dec 8;99(6):532-535. Epub 2017 Oct 8.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12970DOI Listing
December 2017

The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells.

Leuk Lymphoma 2017 11 10;58(11):2705-2716. Epub 2017 Apr 10.

a Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1306647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526721PMC
November 2017

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.

Am J Surg Pathol 2017 Nov;41(11):1483-1490

Departments of *Stem Cell Transplantation and Cellular Therapy †Pathology ‡Gastroenterology, The University of Texas M.D. Anderson Cancer Center §Department of Pediatric Oncology, Baylor College of Medicine, Houston, TX ∥Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000914DOI Listing
November 2017

Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.

Expert Opin Drug Metab Toxicol 2017 Sep 17;13(9):901-923. Epub 2017 Aug 17.

b Department of Stem Cell Transplantation , The University of Texas M.D. Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2017.1360277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584057PMC
September 2017

Prognostic Index for Critically Ill Allogeneic Transplantation Patients.

Biol Blood Marrow Transplant 2017 Jun 3;23(6):991-996. Epub 2017 Mar 3.

Department of Critical Care, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.003DOI Listing
June 2017

Stem cell transplantation outcomes in lymphoblastic lymphoma.

Leuk Lymphoma 2017 02 27;58(2):366-371. Epub 2016 Jun 27.

a Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1193860DOI Listing
February 2017

Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia.

Biol Blood Marrow Transplant 2017 Feb 14;23(2):318-324. Epub 2016 Nov 14.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517662PMC
February 2017

Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells.

Leuk Lymphoma 2016 11 16;57(11):2644-52. Epub 2016 Mar 16.

b Department of Stem Cell Transplantation and Cellular Therapy , UT MD Anderson Cancer Center , Houston , TX , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1157871DOI Listing
November 2016

Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.

Eur J Haematol 2016 Oct 15;97(4):342-7. Epub 2016 Feb 15.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12736DOI Listing
October 2016

Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial.

Bonekey Rep 2016 19;5:843. Epub 2016 Oct 19.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bonekey.2016.72DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154364PMC
October 2016

Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells.

Leuk Res 2016 08 27;47:100-8. Epub 2016 May 27.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.05.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961533PMC
August 2016

Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.

Biol Blood Marrow Transplant 2016 07 16;22(7):1290-1298. Epub 2016 Apr 16.

Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905771PMC
July 2016

Epstein-Barr Virus and B Cells in the Pathogenesis of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell Transplantation.

J Clin Oncol 2016 07 18;34(19):2201-2. Epub 2016 Apr 18.

The University of Texas MD Anderson Cancer Center, Houston, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.6099DOI Listing
July 2016

Cladribine, gemcitabine, busulfan, and SAHA combination as a potential pretransplant conditioning regimen for lymphomas: A preclinical study.

Exp Hematol 2016 06 11;44(6):458-65. Epub 2016 Mar 11.

Department of Stem Cell Transplantation & Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2016.03.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864055PMC
June 2016

Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor.

J Immunother 2016 06;39(5):205-17

*Division of Pediatrics Departments of ‡Biostatistics ∥Neurosurgery §Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center †The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847343PMC
June 2016

Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.

Biol Blood Marrow Transplant 2016 Apr 19;22(4):717-722. Epub 2015 Dec 19.

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828726PMC
April 2016

Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning.

Biol Blood Marrow Transplant 2016 Mar 20;22(3):493-8. Epub 2015 Oct 20.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791150068
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2015.10.015DOI Listing
March 2016

Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review.

J Natl Cancer Inst 2016 Mar 18;108(3). Epub 2015 Nov 18.

Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ (YW, VTC); Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China (FY, YS, WZ, XG); Department of Medicine, University of Chicago, Chicago, IL (JW); Section of Hematology/Oncology, VA New Jersey Health Care System, East Orange, NJ (VTC); Department of Stem Cell Transplantation and Cellular Therapy (BSA, MHQ, REC) and Department of Lymphoma/Myeloma (MLW), The University of Texas MD Anderson Cancer Center, Houston, TX; Institute for Myeloma & Bone Cancer Research, West Hollywood, CA (JRB).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280981PMC
March 2016

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.

J Clin Oncol 2015 Dec 2;33(35):4167-75. Epub 2015 Nov 2.

Steven M. Devine and William Blum, Ohio State University, Columbus, OH; Kouros Owzar, Flora Mulkey, Vera Hars, and Alexander B. Sibley, Alliance Statistics and Data Center, Duke University, Durham; Thomas C. Shea, University of North Carolina, Chapel Hill, NC; Richard M. Stone, Robert J. Soiffer, and Edwin P. Alyea, Dana-Farber Cancer Institute; Yi-Bin Chen, Massachusetts General Hospital, Boston, MA; Jack W. Hsu, University of Florida, Gainesville, FL; Richard E. Champlin, MD Anderson Cancer Research Center, Houston, TX; Ravi Vij, Washington University, St. Louis, MO; James Slack, Mayo Clinic, Scottsdale, AZ; Richard A. Larson, University of Chicago, Chicago, IL; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Shelly Carter, The EMMES Corporation, Bethesda, MD; Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; and Charles Linker, University of California at San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.7273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658453PMC
December 2015